Safety and Effectiveness of Cinnomer ® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran
Condition: Relapsing Multiple Sclerosis Intervention: Drug: Glatiramer Acetate Sponsor: Cinnagen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2021 Category: Research Source Type: clinical trials
